Inovio Pharmaceuticals
INO
#9668
Rank
HK$0.70 B
Marketcap
HK$8.63
Share price
1.85%
Change (1 day)
-51.16%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -HK$22.45

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$22.58. In 2024 the company made an earnings per share (EPS) of -HK$30.97 an increase over its 2023 EPS that were of -HK$47.75.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$22.45-27.53%
2024-HK$30.97-35.14%
2023-HK$47.75-56.62%
2022-HK$110.09-19.54%
2021-HK$136.8335.9%
2020-HK$100.68-11.57%
2019-HK$113.8515.24%
2018-HK$98.80-2.78%
2017-HK$101.626.93%
2016-HK$95.03134.88%
2015-HK$40.46-29.51%
2014-HK$57.40-57.34%
2013-HK$134.55146.55%
2012-HK$54.5720.83%
2011-HK$45.16-29.41%
2010-HK$63.98-48.48%
2009-HK$124.2010%
2008-HK$112.9111.11%
2007-HK$101.62-41.3%
2006-HK$173.13-66.91%
2005-HK$523.16110.61%
2004-HK$248.41-61.63%
2003-HK$647.36186.67%
2002-HK$225.82
2001N/A-100%
2000-HK$180.66-63.64%
1999-HK$496.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.50-403.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$55.04-343.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.27-145.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$53.71-337.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$27.89-223.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$30.47-234.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
HK$2.74-112.15%๐Ÿ‡บ๐Ÿ‡ธ USA